Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors — Peng Zhan (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Shared by
De Clercq Erik
KU Leuven
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Article
2009
en
Authors
+4 more
PZ
Peng Zhan
XL
Xinyong Liu
JZ
Junjie Zhu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
Zihong Yan
,
Hai-Qiu Wu
,
Wenxue Chen
,
Yan Wu
,
Hu‐Ri Piao
,
Qiuqin He
,
Fen‐Er Chen
,
De Clercq Erik
,
Christophe Pannecouque
Article
2008
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Peng Zhan
,
Xinyong Liu
,
Yuan Cao
,
Yan Wang
,
Christophe Pannecouque
,
De Clercq Erik
Article
2014
Synthesis and biological evaluation of DAPY–DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Hai-Qiu Wu
,
Jin Yao
,
Qiuqin He
,
Wenxue Chen
,
Fen‐Er Chen
,
Christophe Pannecouque
,
De Clercq Erik
,
Dirk Daelemans
Article
2012
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
Xuwang Chen
,
Peng Zhan
,
Christophe Pannecouque
,
Jan Balzarini
,
De Clercq Erik
,
Xinyong Liu
Article
2012
Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
Zhenyu Li
,
Yuan Cao
,
Peng Zhan
,
Christophe Pannecouque
,
Jan Balzarini
,
De Clercq Erik
,
Xinyong Liu
Discussion(0)
No comments yet. Be the first to comment.